Dr. Werner Lanthaler is a distinguished biotechnology executive and strategic investor who has dedicated his career to advancing life sciences innovation. As Founder and CEO of WLanholding GmbH, he focuses on investments and advisory services in Life Science and high-tech sustainability companies.
His portfolio includes transformative companies like Proxygen GmbH, Cerabyte GmbH, Solgate GmbH, Planet Pure GmbH, and Cyment. With over two decades of leadership experience, Werner previously transformed Evotec SE from a 200-employee company to a global leader with over 5,000 employees and revenues growing from €40 million to €800 million.
His expertise spans drug discovery innovation, AI integration in biotechnology, and building strategic partnerships that drive scientific breakthroughs. Werner combines deep industry knowledge with a commitment to sustainable innovation, positioning him as a catalyst for the next generation of life sciences advancement.
WLanholding GmbH is a family office and strategic investment platform founded in 2024 by Dr. Werner Lanthaler, focusing on transformative companies in life sciences, high-tech, and sustainability sectors. The platform operates with a long-term investment philosophy, supporting visionary entrepreneurs from seed financing through Series B rounds while providing strategic advisory services and access to Lanthaler's extensive global network built during his tenure as CEO of Evotec SE.
